SHASHANK SARAN

Shashank Saran is an Associate Director in Translational Medicine Oncology at AstraZeneca, specializing in immunotherapy and antibody drug conjugates. They hold a PhD in Molecular Medicine from Hannover Medical School and have over nine years of experience in oncology, focusing on target identification, patient stratification, and mechanisms of action for therapies. Shashank has previously worked as a Senior Scientist and Translational Pathology Lead at AstraZeneca, where they led pathology activities for several immuno-oncology programs and mentored junior colleagues. Their research has been published in Nature Oncogene, and they have contributed significantly to various collaborative projects throughout their career.